BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11374805)

  • 1. Expression of nucleolar organizer regions (NORs) in ovarian epithelial tumors.
    Terlikowski S; Lenczewski A; Famulski W; Sulkowski S; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39(2):161-2. PubMed ID: 11374805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneity of ovarian epithelial tumors in analysis of nucleolar organizer regions (NORs) expression].
    Terlikowski S; Lenczewski A; Sulkowska M; Famulski W; Sulkowski S; Musiatowicz B; Kulikowski M
    Ginekol Pol; 2000 Sep; 71(9):1194-7. PubMed ID: 11083002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors.
    Criscuolo M; Martinelli AM; Migaldi M; Zunarelli E; Bergamaschi M; Falchi AM; De Gaetani C
    Int J Gynecol Pathol; 1993 Jul; 12(3):259-63. PubMed ID: 8344763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining.
    Terlikowski S; Sulkowski S; Lenczewski A; Musiatowicz B; Kulikowski M
    Arch Gynecol Obstet; 1999 Nov; 263(1-2):29-33. PubMed ID: 10728625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions as a prognostic indicator in epithelial cancers of the ovary.
    Sah SP; Dawar R; Kumar L; Gupta SD
    Int J Gynecol Pathol; 2004 Oct; 23(4):347-53. PubMed ID: 15381904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AgNOR distribution in serous tumours of the ovary.
    Mauri FA; Scampini S; Aldovini D; Ferrero S; Barbareschi M; Dalla Palma P
    Pathologica; 1990; 82(1081):487-92. PubMed ID: 1706828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in fallopian tube carcinomas.
    Rabczyńiski JK; Kochman AT; Karmowski A; Woźniak ZM; Bronowicz A; Terpiłowski L
    Clin Exp Obstet Gynecol; 2000; 27(2):125-8. PubMed ID: 10968353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
    Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
    Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of AgNORs in serous ovarian tumors.
    Trabucco S; Varcaccio-Garofalo G; Botticella MA; De Stefano R; Capursi T; Resta L
    Eur J Gynaecol Oncol; 1994; 15(3):222-9. PubMed ID: 7525292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
    Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
    Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva.
    Muscarà M; Giuffré G; Trombetta CJ; Bisantis F; Tuccari G
    Pathologica; 1991; 83(1085):281-8. PubMed ID: 1923626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar organizer regions in laryngeal cancer.
    Klatka J; Skomra D
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():417-21. PubMed ID: 11977351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the AgNORs count in serous ovarian cancer].
    Gottwald L; Danilewicz M; Suzin J; Bieńkiewicz A
    Ginekol Pol; 2004 Oct; 75(10):770-5. PubMed ID: 15587908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in ovarian tumors: discrimination between carcinoma and borderline tumor.
    Khattech A; Spatz A; Prade M; Duvillard P; Charpentier P; Bognel C; Michel G; Lhommé C
    Int J Gynecol Pathol; 1992; 11(1):11-4. PubMed ID: 1373413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of nucleolar organizer regions in lung carcinoma by silver staining.
    Nonomura A; Mizukami Y; Oda M; Shimizu J; Watanabe Y; Kamimura R; Takashima T
    Surg Today; 1993; 23(6):486-90. PubMed ID: 8358192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative AgNOR assessment of cancer cell populations in undifferentiated nasopharyngeal carcinoma.
    Chen M; Lee JC; Lo S
    Anal Quant Cytol Histol; 2002 Apr; 24(2):89-92. PubMed ID: 12026056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.